Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.63 USD | -0.65% | -4.79% | -5.55% |
May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Business Summary
Number of employees: 14
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
INKmune and DN-TNF Product Platform
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -58.56% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -58.56% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Moss
FOU | Founder | 54 | 15-08-31 |
Mark Lowdell
FOU | Founder | 61 | 15-08-31 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Tara Lehner
CTO | Chief Tech/Sci/R&D Officer | - | - |
General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marcia Allen
BRD | Director/Board Member | 73 | 19-11-18 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Scott Juda
BRD | Director/Board Member | 53 | 18-03-12 |
Director/Board Member | 64 | 19-08-07 | |
J. Ganjei
BRD | Director/Board Member | 50 | 16-08-31 |
David Moss
FOU | Founder | 54 | 15-08-31 |
Director/Board Member | 66 | 16-11-30 | |
Mark Lowdell
FOU | Founder | 61 | 15-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 19,782,429 | 13,419,602 ( 67.84 %) | 0 | 67.84 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.55% | 212M | |
+10.56% | 115B | |
+12.31% | 106B | |
-5.27% | 24.69B | |
-1.43% | 21.97B | |
-4.87% | 19.27B | |
-11.04% | 17.56B | |
-39.36% | 17.32B | |
+5.95% | 14.03B | |
+33.53% | 12.13B |
- Stock Market
- Equities
- INMB Stock
- Company INmune Bio, Inc.